Efficacy and safety of tocilizumab with inhibition of interleukin-6 in adult-onset Still’s disease: A meta-analysis
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy and safety of tocilizumab with inhibition of interleukin-6 in adult-onset Still’s disease: A meta-analysis
Authors
Keywords
-
Journal
Modern Rheumatology
Volume -, Issue -, Pages 1-9
Publisher
Informa UK Limited
Online
2017-12-18
DOI
10.1080/14397595.2017.1416924
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Adult-onset Still's disease: Advances in the treatment
- (2016) Santos Castañeda et al. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
- Macrophage activation syndrome associated with tocilizumab treatment in adult-onset Still’s disease
- (2016) Yumi Tsuchida et al. Modern Rheumatology
- Epidemiological study of adult-onset Still’s disease using a Japanese administrative database
- (2016) Nobuo Sakata et al. RHEUMATOLOGY INTERNATIONAL
- Presentation and diagnosis of adult-onset Still’s disease: the implications of current and emerging markers in overcoming the diagnostic challenge
- (2015) Serena Colafrancesco et al. Expert Review of Clinical Immunology
- Efficacy and safety of biological agents in adult-onset Still’s disease
- (2015) G Cavalli et al. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
- Adult onset Still's disease (AOSD) in the era of biologic therapies: Dichotomous view for cytokine and clinical expressions
- (2014) Alexandre Thibault Jacques Maria et al. AUTOIMMUNITY REVIEWS
- Adult-onset Still's disease
- (2014) Mathieu Gerfaud-Valentin et al. AUTOIMMUNITY REVIEWS
- Life-threatening complications of adult-onset Still’s disease
- (2014) Petros Efthimiou et al. CLINICAL RHEUMATOLOGY
- Pathogenesis of adult-onset Still’s disease: new insights from the juvenile counterpart
- (2014) Yvan Jamilloux et al. IMMUNOLOGIC RESEARCH
- Diagnosis and classification of adult Still's disease
- (2014) Naim Mahroum et al. JOURNAL OF AUTOIMMUNITY
- Interleukin 18: A Biomarker for Differential Diagnosis Between Adult-onset Still's Disease and Sepsis
- (2014) R. Priori et al. JOURNAL OF RHEUMATOLOGY
- Tocilizumab in Adult-onset Still's Disease: the Israeli Experience
- (2014) O. Elkayam et al. JOURNAL OF RHEUMATOLOGY
- Benefit and a possible risk of tocilizumab therapy for adult-onset Still’s disease accompanied by macrophage-activation syndrome
- (2014) Masafumi Kobayashi et al. Modern Rheumatology
- Therapeutic response of patients with adult Still’s disease to biologic agents: multicenter results in Japan
- (2014) Rie Suematsu et al. Modern Rheumatology
- The effect of tocilizumab on preventing relapses in adult-onset Still's disease: A retrospective, single-center study
- (2014) Naoshi Nishina et al. Modern Rheumatology
- Nationwide epidemiological survey of 169 patients with adult Still's disease in Japan
- (2014) Yu Funakubo Asanuma et al. Modern Rheumatology
- Efficacy of Tocilizumab in Conventional Treatment-Refractory Adult-Onset Still's Disease: Multicenter Retrospective Open-Label Study of Thirty-Four Patients
- (2014) Francisco Ortiz-Sanjuán et al. Arthritis & Rheumatology
- Tocilizumab for the treatment of adult-onset Still’s disease: results from a case series
- (2013) Paola Cipriani et al. CLINICAL RHEUMATOLOGY
- A genetic role for macrophage migration inhibitory factor (MIF) in adult-onset Still's disease
- (2013) Fang-Fang Wang et al. ARTHRITIS RESEARCH & THERAPY
- Successful treatment of adult-onset Still’s disease with tocilizumab monotherapy: two case reports and literature review
- (2012) Ryota Sakai et al. CLINICAL RHEUMATOLOGY
- Randomized Trial of Tocilizumab in Systemic Juvenile Idiopathic Arthritis
- (2012) Fabrizio De Benedetti et al. NEW ENGLAND JOURNAL OF MEDICINE
- Amplification of the response to Toll-like receptor ligands by prolonged exposure to interleukin-6 in mice: Implication for the pathogenesis of macrophage activation syndrome
- (2011) Raffaele Strippoli et al. ARTHRITIS AND RHEUMATISM
- The Evolution of Adult-Onset Still Disease: An Observational and Comparative Study in a Cohort of 76 Italian Patients
- (2011) Matteo Colina et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Successful treatment of adult-onset Still's disease refractory to TNF and IL-1 blockade by IL-6 receptor blockade
- (2010) J. Rech et al. ANNALS OF THE RHEUMATIC DISEASES
- Tocilizumab in refractory adult Still's disease
- (2010) Xavier Puéchal et al. ARTHRITIS CARE & RESEARCH
- Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
- (2010) David Moher et al. International Journal of Surgery
- A basic introduction to fixed-effect and random-effects models for meta-analysis
- (2010) Michael Borenstein et al. Research Synthesis Methods
- Tocilizumab for multirefractory adult-onset Still's disease
- (2008) M De Bandt et al. ANNALS OF THE RHEUMATIC DISEASES
- Adult-onset Still disease
- (2008) Bruno Fautrel BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now